A-share midday review: The Shanghai Composite Index fell by 0.46%. Resource stocks led the gains. The CSI Consumer 360 index underwent collective adjustment.

By midday, the Shanghai Composite Index fell by 0.46% to 3247.54 points, the Shenzhen Component Index declined by 0.23%, and the Chinext Price Index decreased by 0.28%.

Gelonghui FinanceJan 3 11:46

The State Council meeting deployed to deepen the regulatory reform of Pharmaceutical and medical instruments, and Institutions indicated that there are significant structural opportunities in the Pharmaceutical Industry.

According to media reports, the recent State Council executive meeting deployed measures to deepen the regulation reform of pharmaceuticals and medical instruments, promoting the high-quality development of the pharmaceutical industry. Orient stated that looking back at 2024, the high base from the past has been digested, and the intra-hospital rigid demand is being released normally. Meanwhile, the Industry Chain of Innovative Drugs and the export of instruments continue to yield results, and the overall growth logic is clearly visible.

cls.cnDec 26, 2024 08:09

Lukang Pharma's Four Drugs Get Added to China's Centralized Procurement

MT NewswiresDec 24, 2024 17:39

A-shares movement丨Some influenza Concept stocks rise against the trend, Shandong Lukang Pharmaceutical is approaching its limit up during the session.

Gelonghui, December 23｜Last Friday, Shandong Lukang Pharmaceutical surged during the trading session, approaching a limit up, while Pulike Biological Engineering, Inc., Guangdong Zhongsheng Pharmaceutical, Zhejiang Medicine, and Beijing Tiantan Biological Products Corporation all saw increases. In news, the Peking Center for Disease Control recently announced that the city has entered a high flu season. The disease control department reminds citizens that if they experience fever, cough, or other flu-like symptoms, they should try to avoid crowded places and not go to work or school while sick. Additionally, it has been reported that Japan has entered a flu outbreak period, with about 2,800 schools and kindergartens facing class suspensions. (Gelonghui)

Gelonghui FinanceDec 23, 2024 10:40

Shandong Lukang Pharmaceutical (600789.SH): Signed a "Trademark License Agreement" with related parties.

Gelonghui, December 20, Shandong Lukang Pharmaceutical (600789.SH) announced that the "Lukang" registered trademark and related product trademarks are owned by Hualu Group. In April 2022, the company reached a trademark licensing agreement with Hualu Group regarding the "Lukang" registered trademark and related product trademarks, charging the company an annual trademark usage fee of 7.6 million yuan, with the agreement valid for three years (2022-2024). In view of the upcoming expiration of the aforementioned trademark licensing agreement, negotiations between the company and Hualu Group are underway to renew the trademark licensing agreement. The annual usage fee is...

Gelonghui FinanceDec 20, 2024 19:43

Express News | Shandong Lukang Pharmaceutical: plans to raise no more than 1.2 billion yuan through a private placement.

BreakingsDec 20, 2024 19:23